ArticleCancer science2022

CPI-203 improves the efficacy of anti-PD-1 therapy by inhibiting the induced PD-L1 overexpression in liver cancer.

Xiaoge Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.